PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,320 | -98.7% | 26,100 | -92.6% | 0.00% | -100.0% |
| Q1 2023 | $342,072 | -4.4% | 350,484 | +1.9% | 0.01% | -15.4% |
| Q4 2022 | $357,691 | -1.5% | 343,934 | +9.0% | 0.01% | -7.1% |
| Q3 2022 | $363,000 | -38.5% | 315,634 | +0.1% | 0.01% | -33.3% |
| Q2 2022 | $590,000 | -46.0% | 315,384 | -12.6% | 0.02% | -36.4% |
| Q1 2022 | $1,093,000 | -19.5% | 360,834 | +0.4% | 0.03% | -13.2% |
| Q4 2021 | $1,358,000 | -27.9% | 359,234 | -1.4% | 0.04% | -33.3% |
| Q3 2021 | $1,884,000 | +36.7% | 364,484 | +1.3% | 0.06% | +39.0% |
| Q2 2021 | $1,378,000 | +127.8% | 359,800 | +52.7% | 0.04% | +115.8% |
| Q1 2021 | $605,000 | +4.3% | 235,600 | +1.6% | 0.02% | -5.0% |
| Q4 2020 | $580,000 | +26.9% | 231,900 | +4.9% | 0.02% | +11.1% |
| Q3 2020 | $457,000 | -18.8% | 221,000 | +21.8% | 0.02% | -28.0% |
| Q2 2020 | $563,000 | +160.6% | 181,500 | +91.6% | 0.02% | +92.3% |
| Q1 2020 | $216,000 | – | 94,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |